Sustainable value creation in the commercialisation of innovation: the case of Auria Biobank

Hanna Lehtimäki, Ilpo Helén, Karoliina Snell, Päivi Eriksson and Tero Montonen

International Journal of Entrepreneurship and Innovation Management, 2019, vol. 23, issue 5, 451-465

Abstract: The purpose of this study is to examine how different logics of commercialisation are part of sustainable value creation in an emerging area of healthcare. This paper presents an inductive interpretative case study to examine the emerging field of personalised medicine from the perspective of a biobank seeking to create value on its depository of tissue samples, patient records, and digitised data. This study increases our understanding of the challenges and opportunities faced by a company when developing innovations in healthcare. It contributes to the literature on the commercialisation of innovation by exploring how sustainable value creation in an emerging industry builds on both planned and emergent commercialisation activities and how different logics of commercialisation are a part of sustainable value creation in personalised medicine.

Keywords: healthcare; innovation; commercialisation; value creation; stakeholder; biobank; personalised medicine. (search for similar items in EconPapers)
Date: 2019
References: Add references at CitEc
Citations:

Downloads: (external link)
http://www.inderscience.com/link.php?id=102035 (text/html)
Access to full text is restricted to subscribers.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:ids:ijeima:v:23:y:2019:i:5:p:451-465

Access Statistics for this article

More articles in International Journal of Entrepreneurship and Innovation Management from Inderscience Enterprises Ltd
Bibliographic data for series maintained by Sarah Parker ().